Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

New asthma treatment now available in Canada

June 17, 1997

Milkhaus receives FDA approval to start phase II cystic fibrosis trial

June 17, 1997

IND for gene therapy for cystic fibrosis approved

June 13, 1997

NIH funds high-throughput screening in allergic inflammation and immunology by Cadus

June 11, 1997

Inflazyme granted Australian patent for antiinflammatory agents

June 9, 1997

Aciclovir demonstrates antiasthmatic activity in animal model

June 9, 1997

Clinical trials for Albuterol Spiros completed

June 6, 1997

Potent LT biosynthesis inhibitors described by Abbott

June 6, 1997

Dual H1 and CysLT1 antagonist reported by Dutch and Japanese researchers

June 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...